Literature DB >> 17005100

Acute disseminated encephalomyelitis in North Indian children: clinical profile and follow-up.

Pratibha D Singhi1, Munni Ray, Sunit Singhi, Narendra Kumar Khandelwal.   

Abstract

Acute disseminated encephalomyelitis in children is not uncommon in developing countries, yet there is little systematic documentation of its clinical profile and follow-up. We studied the clinical and neuroradiologic features of acute disseminated encephalomyelitis in 52 consecutive children. Clinical details, magnetic resonance imaging (MRI) findings, and the results of other investigations were recorded, and children were followed up from 6 to 48 months. A repeat MRI was done after 3 to 4 months, and in those with persistent lesions, another MRI was done after 6 to 7 months of discharge. The mean age at presentation was 6.14 +/- 3.17 years, 73.1% were male, and 17 children had a history of antecedent infectious illness or vaccination. Most children had a meningoencephalitic presentation, with sudden-onset motor weakness in 76.9% and seizures in 36.5%. Altered sensorium and pyramidal signs were seen in 55.8% and 80.7% of children, respectively. On MRI, scattered T(2)-weighted hyperintense lesions were seen, mainly in the subcortical white matter, especially in the parietal (53.8%) and frontal (30.17%) regions. Thalamic, basal ganglia, and callosal lesions were seen in 30.76%, 17.3%, and 13.46% of cases, respectively. Variable contrast enhancement was seen in 48% of those who had contrast MRIs. The response to methylprednisolone was good, with dramatic recovery in 26.9% and marked improvement in 51.9% at discharge. On follow-up, of 44 children, residual smaller MRI lesions were seen in 30. The MRI was repeated at 6 months in children with residual lesions, and it was found that the lesions either disappeared or were significantly reduced after 6 months in 75% of cases. Four children had relapse of acute disseminated encephalomyelitis with new lesions on MRI. All of them responded to methylprednisolone. None of the clinical or neuroradiologic factors at presentation had any significant correlation with relapse. Six months after discharge, no deficits could be found in 61.3% of cases; 15.9% and 4.5% had motor and cognitive deficits, and 9% had multiple deficits. The presentation of pediatric acute disseminated encephalomyelitis in developing countries is similar to that in developed countries. In spite of an aggressive presentation, most children respond well to corticosteroids. MRI lesions disappear or are significantly reduced at 6 months in the majority of cases.

Entities:  

Mesh:

Year:  2006        PMID: 17005100     DOI: 10.1177/08830738060210100201

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  13 in total

1.  Acute disseminated encephalomyelitis.

Authors:  Rajoo Thapa; Debkrishna Mallick; Apurba Ghosh
Journal:  Indian J Pediatr       Date:  2009-01       Impact factor: 1.967

2.  Pediatric neurology. Editorial.

Authors:  Pratibha Singhi
Journal:  Indian J Pediatr       Date:  2008-11       Impact factor: 1.967

3.  Treatment of acute disseminated encephalomyelitis.

Authors:  Daniela Pohl; Silvia Tenembaum
Journal:  Curr Treat Options Neurol       Date:  2012-06       Impact factor: 3.972

4.  Acute disseminated encephalomyelitis: Treatment guidelines.

Authors:  M Alexander; J M K Murthy
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

5.  Clinical profile of acute disseminated encephalomyelitis in children.

Authors:  M P Jayakrishnan; P Krishnakumar
Journal:  J Pediatr Neurosci       Date:  2010-07

6.  Acute disseminated encephalomyelitis: case report and brief review.

Authors:  Pratyush Kumar; Praveen Kumar; R K Sabharwal
Journal:  J Family Med Prim Care       Date:  2014 Oct-Dec

7.  A nationwide survey of pediatric acquired demyelinating syndromes in Japan.

Authors:  Y Yamaguchi; H Torisu; R Kira; Y Ishizaki; Y Sakai; M Sanefuji; T Ichiyama; A Oka; T Kishi; S Kimura; M Kubota; J Takanashi; Y Takahashi; H Tamai; J Natsume; S Hamano; S Hirabayashi; Y Maegaki; M Mizuguchi; K Minagawa; H Yoshikawa; J Kira; S Kusunoki; T Hara
Journal:  Neurology       Date:  2016-10-14       Impact factor: 9.910

8.  Acute disseminated encephalomyelitis: a call to the clinicians for keeping this rare condition on clinical radar.

Authors:  Liaqat Ali Chaudhry; Waseem Babur; Ghazala Aslam Chaudhry; Feddah Eid Al-Atawi; Asirvatham Alwin Robert
Journal:  Pan Afr Med J       Date:  2018-03-02

Review 9.  Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome.

Authors:  Diederik L H Koelman; Farrah J Mateen
Journal:  J Neurol       Date:  2015-03-13       Impact factor: 6.682

10.  Acute Disseminated Encephalomyelitis-Masquerading as Pediatric Stroke: Case Report.

Authors:  Varsha H Chauhan; Richa Chaudhary; Payal Meshram
Journal:  J Pediatr Neurosci       Date:  2018 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.